Search Results 41-50 of 14817 for anti-TNF drugs

  1. Adalimumab-Adbm (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Adalimumab-Afzb (Subcutaneous Route) Precautions - Mayo Clinic

    Do not take other medicines unless they have been discussed with your doctor. Using abatacept (Orencia®) or anakinra (Kineret®) together with this medicine may ...

  3. Adalimumab-Aaty (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Etanercept (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    Anti-TNF Therapy. Inadequate primary non-response: Did not respond (as ... Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs). Prophylactic ...

  6. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

    The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

  7. Mayo Clinic Q&A podcast Dr. Faubion IBD

    drugs begin to affect the immune system body wide, okay. ... All of these affect TNF, we call them anti TNF. ... Does it traffic to the colon or not, the so-called ...

  8. Adalimumab-Bwwd (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  9. Hidradenitis suppurativa - Diagnosis and treatment - Mayo Clinic

    Two are the tumor necrosis factor inhibitors adalimumab, or Humira, and infliximab, or Remicade. These medicines work by dampening part of the immune system ...

  10. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...